<DOC>
	<DOCNO>NCT00703599</DOCNO>
	<brief_summary>The purpose study determine whether intravenous administration autologous adipose stem cell safe beneficial patient type 1 diabetes .</brief_summary>
	<brief_title>Safety Efficacy Autologous Adipose-Derived Stem Cell Transplantation Patients With Type 1 Diabetes</brief_title>
	<detailed_description>Diabetes Mellitus large epidemic proportion worldwide . It proliferate fast rate new novel drug therapeutic approach require . The purpose Phase I/II study determine whether intravenous administration activate adipose-derived stromal vascular fraction single procedure safe efficacious patient Type 1 Diabetes Mellitus . Patients observe 12 month follow procedure , 2 week , 1 month tri-monthly diagnostics life style questionaires .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Confirmed diagnosis Type I diabetes least 2 year Insulindependent Presence acute diabetic complication acute stage recent myocardial infarction , recent CVA acute renal failure .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Adipose-derived stem cell</keyword>
	<keyword>Adipose stromal vascular fraction</keyword>
	<keyword>Autologous</keyword>
	<keyword>Insulin-dependence</keyword>
</DOC>